Evidence review

What Are Peptides for GLP-1 Gut

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `what-are-peptides-glp1-gut`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/what-are-peptides-glp1-gut

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/what-are-peptides-glp1-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/what-are-peptides-glp1-gut/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/what-are-peptides-glp1-gut/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/what-are-peptides-glp1-gut/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why GLP-1 agonists (class) matters for you

  1. Drug: GLP-1 agonists (class)
  2. What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.44 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity (source s1)

Human RCT showing delayed gastric emptying with semaglutide.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Adverse effects of GLP-1 receptor agonists as glucose-lowering agents (source s2)

Review summarizing GI adverse event data from RCTs.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation (source s3)

Discussion of body composition changes with GLP-1 use.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

GLP-1 agonists · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpWhat Are Peptides? · 19 humanChemo Neuropathy · 4 humanBrain Fog · 3 humanChemo · 3 human
Evidence · 3 sources · swipe →chain b3b9e201a336 · verify chain · provenance
1 / 3
Evidence ledger 3 · tier-ranked · API
human
Semaglutide 1.0 mg weekly increased 4-hour solid meal gastric retention to 37% versus 0% on placebo in a human RCT of women with PCOS and obesity.
sources: s1
human
GLP-1 agonists increase risk of nausea, vomiting, diarrhea, and constipation versus placebo across multiple systematic reviews of RCTs.
sources: s2
humanlow confidence
Lean mass can account for 15-40% of weight loss with GLP-1 therapies in some reports, though not always disproportionate to dietary restriction alone.
sources: s3
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:00
What Are Peptides for GLP-1 Gut · 3 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: What Are Peptides for Glp1 Gut
Slug: what-are-peptides-glp1-gut
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[],"drugs_in_scope":["glp1-agonists"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerati
it output
{
  "slug": "what-are-peptides-glp1-gut",
  "title": "What Are Peptides for GLP-1 Gut",
  "body": "## What's breaking down\n\nGLP-1 agonists are peptide-based drugs that mimic the natural GLP-1 hormone. They act on the gut by slowing gastric emptying and intestinal motility. This slows the movement of food through the digestive tract.\n\nIf gastric emptying slows markedly, food stays in the stomach longer. This can lead to feelings of fullness but also nausea or vomiting in many users. The same slowing can contribute to constipation or diarrhea depending on individual response and dose timing.\n\nThe core tradeoff is metabolic support versus potential gut signal suppression. The drug reduces appetite signals and caloric intake through gut effects. At the same time, it can suppress normal motility patterns that support comfortable digestion. Rapid weight loss from these drugs may also involve lean mass changes, which some studies link to overall body composition shifts rather than a unique drug effect beyond calorie restriction.\n\n## Why GLP-1 agonists (class) matters for you\n\n1. **Drug:** GLP-1 agonists (class) such as semaglutide.\n2. **What it does:** Provides metabolic benefit through appetite reduction and delayed gastric emptying, while carrying tradeoffs of gut slowing and potential muscle or lean mass loss during rapid weight reduction.\n3. **Therefore for you:** This
79ebdca1a08f0b79

Related research

GLP-1 agonists · drug map

Open evidence map →
What Are Peptides?what-are-peptidesBenzo Withdrawalwhat-are-peptides-benzo-withdrawalPeptides and Benzodiazepines: What the Evidence Showswhat-are-peptides-benzodiazepinesBrain Fogwhat-are-peptides-brain-fogCarpal Tunnelwhat-are-peptides-carpal-tunnelChemowhat-are-peptides-chemoChemo Neuropathywhat-are-peptides-chemo-neuropathyCognitionwhat-are-peptides-cognitionCorticosteroidswhat-are-peptides-corticosteroidsDiabetic Neuropathywhat-are-peptides-diabetic-neuropathy
Ask this article · 5 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Semaglutide 1.0 mg weekly increased 4-hour solid meal gastric retention to 37% versus 0% on placebo in a human RCT of women with PCOS and ob…"?
ask what-are-peptides-glp1-gut claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "GLP-1 agonists increase risk of nausea, vomiting, diarrhea, and constipation versus placebo across multiple systematic reviews of RCTs."?
ask what-are-peptides-glp1-gut claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Lean mass can account for 15-40% of weight loss with GLP-1 therapies in some reports, though not always disproportionate to dietary restrict…"?
ask what-are-peptides-glp1-gut claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about What Are Peptides for GLP-1 Gut — and what would you need me to tell you first?
ask what-are-peptides-glp1-gut condition gaps · paste includes §SELF
What good and bad outcomes are documented for What Are Peptides for GLP-1 Gut (studies vs anecdotes)?
ask what-are-peptides-glp1-gut good bad experiences · paste includes §SELF
what-are-peptides-glp1-gut · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 31560 tokens · $0 · 1 model
chain head f1414e1626ba0c02
write grok/grok-4.3 · 2026-06-29 22:00 · 31560 tok · f1414e1626ba
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
webhook_in blooio · 2026-06-29 22:01
PROTOCOL_RUN dispatch · 2026-06-29 22:01 · t_gnwitlgc
PROTOCOL_RUN dispatch · 2026-06-29 22:01 · t_gnwitlgc
webhook_in blooio · 2026-06-29 22:01
webhook_in blooio · 2026-06-29 22:01
webhook_in blooio · 2026-06-29 22:01
view full ledger & cards →
REST + ledger
read GET /api/articles/what-are-peptides-glp1-gut · GET /api/articles/what-are-peptides-glp1-gut?format=post (the editable body)
create/replace POST /api/articles/what-are-peptides-glp1-gut · PUT /api/articles/what-are-peptides-glp1-gut (replace, keeps revision) · PATCH /api/articles/what-are-peptides-glp1-gut (merge)
delete DELETE /api/articles/what-are-peptides-glp1-gut
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/what-are-peptides-glp1-gut/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/what-are-peptides-glp1-gut/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim what-are-peptides-glp1-gut|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →